Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study Article

Koebel, M, Madore, J, Ramus, SJ et al. (2014). Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study . BRITISH JOURNAL OF CANCER, 111(12), 2297-2307. 10.1038/bjc.2014.567

Open Access International Collaboration

cited authors

  • Koebel, M; Madore, J; Ramus, SJ; Clarke, BA; Pharoah, PDP; Deen, S; Bowtell, DD; Odunsi, K; Menon, U; Morrison, C; Lele, S; Bshara, W; Sucheston, L; Beckmann, MW; Hein, A; Thiel, FC; Hartmann, A; Wachter, DL; Anglesio, MS; Hogdall, E; Jensen, A; Hogdall, C; Kalli, KR; Fridley, BL; Keeney, GL; Fogarty, ZC; Vierkant, RA; Liu, S; Cho, S; Nelson, G; Ghatage, P; Gentry-Maharaj, A; Gayther, SA; Benjamin, E; Widschwendter, M; Intermaggio, MP; Rosen, B; Bernardini, MQ; Mackay, H; Oza, A; Shaw, P; Jimenez-Linan, M; Driver, KE; Alsop, J; Mack, M; Koziak, JM; Steed, H; Ewanowich, C; DeFazio, A; Chenevix-Trench, G; Fereday, S; Gao, B; Johnatty, SE; George, J; Galletta, L; Goode, EL; Kjaer, SK; Huntsman, DG; Fasching, PA; Moysich, KB; Brenton, JD; Kelemen, LE

sustainable development goals

authors

publication date

  • December 9, 2014

published in

keywords

  • BINDING
  • CANCER
  • EPITHELIAL OVARIAN
  • FARLETUZUMAB
  • FOLATE-RECEPTOR-ALPHA
  • FRA
  • Life Sciences & Biomedicine
  • MONOCLONAL-ANTIBODY
  • Oncology
  • PROGNOSIS
  • RISK
  • Science & Technology
  • TCGA
  • THERAPY
  • WOMEN
  • folate receptor alpha
  • immunohistochemistry
  • ovarian cancer
  • prognosis

Digital Object Identifier (DOI)

publisher

  • SPRINGERNATURE

start page

  • 2297

end page

  • 2307

volume

  • 111

issue

  • 12